Creative Medical Technology Holdings, Inc. Deferred Revenue
Creative Medical Technology Holdings, Inc. (CELZ) had Deferred Revenue of $0 as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-08-07
- 2026-06-30: Deferred Revenue $0.00.
- 2025-12-31: Deferred Revenue $0.00.
- 2025-09-30: Deferred Revenue $0.00.
- 2025-06-30: Deferred Revenue $0.00.
| Period end | Deferred Revenue |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-07 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 |
| 2024-12-31 | $40.00K 10-Q · filed 2025-11-07 |
| 2024-09-30 | $43.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $40.00K 10-Q · filed 2024-08-09 |
| 2023-12-31 | $40.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $40.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $40.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $40.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $40.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $55.00K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-03-24 | $40.00K 10-Q · filed 2024-05-10 |
| 2021-12-31 | $30.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $32.00K 10-K · filed 2021-03-17 |
| 2019-12-31 | $30.00K 10-K · filed 2020-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |